References
- 1. Raab M S, Podar K, Breitkreutz I et al. Multiple myeloma. Lancet 2009; 374:324 - 339.
- 2. Joan Blade, Carlos Fernandez de Larrea, Laura Rosinol. Extramedullary involvement in multiple myeloma. Haematologica. 2012 Nov; 97(11): 1618-1619.10.3324/haematol.2012.078519
- 3. Blade J, Fernandez de Larrea C, Rosinol L, Cibeira MT, Jimenez R, Powles R. SoftTissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol. 2011;29(28):3805-12.10.1200/JCO.2011.34.9290
- 4. Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ. The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma. 2009 Feb;50(2):230-5.
- 5. Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: longitudinal study on 1,003 consecutive patients. Ann Oncol. 2009;21(2):325-30.
- 6. Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, et al. The impact of extramedullary disease at presentation in outcome of myeloma. Leuk Lymphoma. 2009;50(2):230-5.
- 7. Blade J, Lust J, Kyle RA. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 patients. J Clin Oncol. 1994;12(11):2398-404.10.1200/JCO.1994.12.11.2398
- 8. Blade J, Kyle RA, Greipp PR. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Heamatol. 1996;93(2):345-51.
- 9. Soutar R, Lucraft H, Jackson G, Reece A, Bird J, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004 Mar;124(6):717-26.
- 10. Menke DM1, Horny HP, Griesser H, Tiemann M, Katzmann JA, et al. Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol. 2001 Jan;115(1):119- 26.
- 11. Masood A, Hudhud KH, Hegazi A, Syed G. Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma. Cases J. 2008 Aug 21;1(1):116.
- 12. Miyazaki T, Kohno S, Sakamoto A, Komori K, Sasagawa I et al. A rare case of extramedullary plasmacytoma in the mediastinum. Intern Med. 1992 Dec;31(12):1363-5.
- 13. Kazama T, Ng CS, Giralt SA. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005 JulAug;29(4):263-5.
- 14. Aguado B, Inigo B, Sastre JL, Oriol A. Extramedullary plasmacytomas in the context of multiple myeloma. Adv Ther. 2011 Nov;28 Suppl 7:7-13.10.1007/s12325-011-0073-6
- 15. Touzeau C, Moreau P. How I treat extramedullary myeloma. Blood. 2016 Feb 25;127(8):971-6.
- 16. Rosiñol L, Cibeira MT, Blade´ J, et al: Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 89:832-836, 2004.
- 17. Avigdor A, Raanani P, Levi I, et al: Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma 42:683-687, 2001.
- 18. Myers B, Grimley C, Crouch D, et al: Lack of response to thalidomide in plasmacytomas. Br J Haematol 115:234, 2001.
- 19. Nakazato T, Suzuki K, Mihara A, et al. Refractory plasmablastic type myeloma with multiple extra medullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone. Intern Med. 2009;48:1827-1832.10.2169/internalmedicine.48.2142
- 20. Gonzalez-Porras JR, Gonzalez M, Garcia-Sanz R, et al. Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas. Br J Haematol. 2002;119:883-884.